Description
Sunitinib Malate, sold under the brand name Rcnet, It is licensed for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). Sunitinib Malate is available as a generic medicine in the India.
What is Sunitinib Malate Capsules used for?
It is an anti-cancer medication. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) in January 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications. As of August 2021,
Will this product be accessible across all regions of India?
The product –Rcnet (Sunitinib Malate) Capsules will be available across India on request. It is available in all the major cities in India – Delhi, Gurgain, Noida, Chandigarh, Srinagar, Jammu, Hyderabad, Chennai, Bangalore, Ahmedabad, Surat, Mumbai, Pune, Kolkata, Jaipur, Jodhpur, Hyderabad, Lucknow, Patna.
How can Aark Pharmceuticals help?
To learn about the cost price of Sunitinib or to order Sunitinib online, please contact:
📞 Ms. Himanshi: 9999156233
📧 Email: sales@aarkpharma.co.in, sales@aarkpharma.com
We ensure genuine quality, secure delivery, and compliance with all buyer requirements.
Aark Pharma network in India – New Delhi | Lucknow | Varanasi | Chandigarh | Kolkata | Patna | Jodhpur.
Prior to consuming any medications, including Sunitinib Capsule, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
List of available and accessible generic brand of Sunitinib Malate Capsules?
Generic brand of Sunitinib Malate available and accessible to patients at an affordable price, at the earliest possible time: Sutent | Tunib | Sunixar | Sutib | Sutinat | Sunishil | Sunimaps | Nitnib
NEWS / Updates
- Sunitinib
- FDA approves sunitinib malate for adjuvant treatment of renal cell carcinoma
- Glenmark launches SUTIB (Sunitinib) capsules in India to treat kidney cancer
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
01 Oct 2024 | 07:25 AM (IST)





